Extended Data Fig. 4: IDI-NRI analysis of MRI-PTPCa compared to clinical approaches for PCa diagnosis.
From: An MRI–pathology foundation model for noninvasive diagnosis and grading of prostate cancer
a) Comparison between PSA and MRI-PTPCa. b) Comparison for PSA gray zone (4-10 ng/mL) between PSA and MRI-PTPCa. c) Comparison for PAS gray zone between PI-RADS and MRI-PTPCa. The events indicated PCa diagnosis, and nonevents indicated non-PCa. The confidence intervals were computed using a 1000-times bootstrapping strategy with replacement. Error bars represent the error between the NRI value of the prediction model and the reference. Error bands represent IDI value. The n indicated on the diagram represents numbers of patients.
